Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rises 6.05% in Morning Trade, Turnover at HKD 420 Million
NewTimeSpace News: As of August 20 at 11:12, Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) rose 6.05%, with a latest price of HKD 16.480, an opening price of HKD 15.700, a high of HKD 16.690, a low of HKD 15.700, and an intraday amplitude of 6.37%. The ETF traded 25.5917 Million shares, with a turnover of HKD 420 Million and an average price of HKD 16.428. The premium rate is -0.12%, with a turnover rate of 15.36%. The current Net Asset Value (NAV) is HKD 15.558, with Assets Under Management (AUM) of HKD 2.592 Billion, total outstanding shares of 167 Million, and a lot size of 100 shares.
Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) tracks the Hang Seng Biotechnology Index. Its constituent stocks focus on pharmaceuticals, biotechnology, medical devices and other related sectors.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Akeso Drug Fails FDA Review; Chinaamc HK Biotech ETF (03069.HK) -2.22%
- ChinaAMC Hang Seng Biotech ETF (03069.HK) Down 2.23% as Akeso Slides 22.6%
- ChinaAMC Hang Seng Biotech ETF (03069.HK) Up 1.86% as Hong Kong Biotech Rallies
- ChinaAMC Hang Seng Biotech ETF (03069.HK) Up 2.69% Intraday as 124 Drugs Enter Medical Insurance Bargaining
- ChinaAMC Hang Seng Biotech ETF (03069.HK) Falls 2.33% Intraday as Hong Kong Pharma Stocks Slip